English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1983]
News [3215]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
DNA annotations predict patient outcomes in childhood leukaemia
DNA annotations predict patient outcomes in childhood leukaemia
ESMO publishes new position paper on supportive and palliative care
ESMO publishes new position paper on supportive and palliative care
New research linking cancer-inhibiting proteins to cell antennae
New research linking cancer-inhibiting proteins to cell antennae
Patients with HIV-associated lymphoma can safely continue anti-retroviral therapy during chemotherapy
Patients with HIV-associated lymphoma can safely continue anti-retroviral therapy during chemotherapy
ASH 2017: Study identifies agent that can reverse resistance to targeted drug in some leukaemia
ASH 2017: Study identifies agent that can reverse resistance to targeted drug in some leukaemia
New discovery may enhance chemotherapy's efficiency against leukaemia
New discovery may enhance chemotherapy's efficiency against leukaemia
ASH 2017: Targeted leukaemia drug venetoclax found superior to standard chemotherapy for broad range of patients when combined with rituximab
ASH 2017: Targeted leukaemia drug venetoclax found superior to standard chemotherapy for broad range of patients...
ASH 2017: Largest-ever trial shows direct oral anticoagulants are a viable option for treating blood clots in patients with cancer
ASH 2017: Largest-ever trial shows direct oral anticoagulants are a viable option for treating blood clots in...
ASH 2017: Trial supports addition of daratumumab to standard treatment regimen for patients with multiple myeloma
ASH 2017: Trial supports addition of daratumumab to standard treatment regimen for patients with multiple myeloma
ASH 2017: AML study reports high response rates with combination targeted therapy
ASH 2017: AML study reports high response rates with combination targeted therapy
<1...140141142143144...322>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top